All News #Library
Sciences
Alumis` Envudeucitinib Succeeds in Phase 3 Psoriasis Trial
28 Mar 2026 //
GLOBENEWSWIRE
Esker, a new biotech startup, launches with plans to make targeted immune drugs
05 May 2021 //
BIOPHARMADIVE

Market Place
Sourcing Support